Active surveillance: Oncologic outcome

Current Opinion in Urology

Volumn 23, Issue 3, 2013, Pages 268-272

  Venderbos, Lionne D F ^a   Bokhorst, Leonard P ^a   Bangma, Chris H ^a   Roobol, Monique J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

active surveillance; mortality; oncologic outcome; prostate cancer; prostate cancer specific mortality

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FOLLOW UP; GLEASON SCORE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; WATCHFUL WAITING;

DISEASE PROGRESSION; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNNECESSARY PROCEDURES; WATCHFUL WAITING;

EID: 84876412025     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32835efe8f     Document Type: Review

References (19)

1. Klotz L. Active surveillance: the Canadian experience. Curr Opin Urol 2012; 22:222-230.
2. Ischia JJ, Pang CY, Tay YK, et al. Active surveillance for prostate cancer: an Australian experience. BJU Int 2012; 109 (Suppl 3):40-43.
3. Whitmore WF Jr. Localised prostatic cancer: management and detection issues. Lancet 1994; 343:1263-1267. (Pubitemid 24158051)
4. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol 1991; 30:133-140.
5. Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366:981-990.
6. Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010; 11:725-732.
7. Van den Bergh RC, Vasarainen H, van der Poel HG, et al. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study. BJU Int 2010; 105:956-962.
8. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367:203-213.
9. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364:1708-1717.
10. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347:781-789. (Pubitemid 34988336)
11. Wilt TJ, Brawer MK, Barry MJ, et al. The Prostate cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Contemp Clin Trials 2009; 30:81-87.
12. Godtman R, Holmberg E, Khatami A, et al. Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial. Eur Urol 2013; 63:101-107.
13. Bul M, Zhu X, Valdagni R, et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 2012 [Epub ahead of print].
14. Tosoian JJ, Trock BJ, Landis P, et al. Active surveillance program for prostate cancer: an update of the John Hopkins experience. J Clin Oncol 2011; 29:2185-2590.
15. Xia J, Trock BJ, Cooperberg MR, et al. Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clin Cancer Res 2012; 18:5471-5478.
16. Bul M, Zhu X, Rannikko A, et al. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol 2012; 62:195-200.
17. Dall'Era MA, Cowan JE, Simko J, et al. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int 2011; 107:1232-1237.
18. Vasarainen H, Lokman U, Ruutu M, et al. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int 2012; 109:1614-1649.
19. Van den Bergh RC, Korfage IJ, Roobol MJ, et al. Sexual function with localized prostate cancer: active surveillance vs. radical therapy. BJU Int 2012; 110:1032-1039.